The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response to checkpoint inhibition in lung cancer with molecular driver alterations.
 
Amanda Tufman
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly; Novartis; Roche
Research Funding - Celgene
 
Kathrin Kahnert
Consulting or Advisory Role - Chugai Pharma; Novartis; Roche
 
Diego Kauffmann-Guerrero
Consulting or Advisory Role - Boehringer Ingelheim; Roche
 
Benjamin-Alexander Bollmann
No Relationships to Disclose
 
Simone Reu
No Relationships to Disclose
 
Zulfiya Syunyaeva
Travel, Accommodations, Expenses - Lilly
 
Christian Schneider
No Relationships to Disclose
 
Farkhad Manapov
Consulting or Advisory Role - Novartis
 
Thomas Wehler
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
 
Rudolf M. Huber
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Clovis Oncology; Guardant Health; Lilly; Merck; Mologen; Novartis; Pfizer; Roche; Takeda
 
Heiko Golpon
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche